HE chromatin control, preparation method and application thereof
By setting up dual smear regions of mature erythrocytes and lymphocytes from mammalian peripheral blood on a glass slide and combining them with microspectrophotometry, the problem of strong subjectivity and insufficient objectivity in HE staining quality control has been solved, achieving stable and standardized staining quality control, which is suitable for clinical pathology and AI diagnosis.
Patent Information
- Application Number
- CN202610800964.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-06-04
- Publication Date
- 2026-08-25
AI Technical Summary
Existing HE staining quality control methods rely on subjective human judgment, resulting in poor objectivity and difficulty in achieving quantitative, stable, and standardized quality control, thus failing to meet the needs of clinical pathology testing.
A HE staining quality control material is provided, comprising setting a first smear area and a second smear area on the same glass slide, respectively smearing mature erythrocytes and lymphocytes from mammalian peripheral blood, detecting the absorbance value using a microspectrophotometer, and determining the quality by combining the absorbance value range with reference absorbance value.
It enables independent quality control of nuclear and plasma staining, eliminates the baseline bias caused by differences in human tissue donors, provides a stable and objective evaluation of staining quality, improves the accuracy and consistency of staining quality control, and meets the needs of clinical pathology quantitative quality control and AI diagnosis.